STB is driven to develop versatile artificial viruses (i.e., synthetic virus-like nanoparticles; non-viral vectors) that serve as an ideal alternative to viral vectors for targeted delivery of therapeutic cargos (e.g., plasmid DNA, siRNA, shRNA, CRISPR/Cas9). Unlike viral vectors that have several drawbacks including immunogenicity, cytotoxicity, biosafety requirements for handling infectious material, laborious production procedures, and high costs, our patent-pending delivery technology offers safe, potent, easy-to-use, and cost-effective delivery systems that can efficiently and effectively deliver cargos in a site-specific manner for in vitro molecular biology applications as well as ex vivo and in vivo gene therapies.
Company Details
- Founded
- -
- Address
- 151 Charles St W, Kitchener,ontario N2g,canada
- Industry
- Biotechnology
- Website
- http://www.stbiosystem.com
- HQ
- Kitchener, Ontario
Soft Transport Biosystem Inc. Questions
Soft Transport Biosystem Inc.'s website is http://www.stbiosystem.com
Soft Transport Biosystem Inc.'s LinkedIn profile is https://ca.linkedin.com/company/soft-transport-biosystem
Soft Transport Biosystem Inc.'s industry is
Biotechnology
Soft Transport Biosystem Inc.'s top competitors are
Skin Life Analytics,
Nvigen Inc.,
Hera Biolabs,
Couragene,
Trioxnano - Programmed Medicine,
Entwine Bio,
Generatixe, Inc.,
I-Dna Biotechnology Pte Ltd,
Infirmacea Inc.,
Neurosense Technologies.
Soft Transport Biosystem Inc.'s categories are Biotechnology
Soft Transport Biosystem Inc.'s founding year is 2017
